More articles from Technological Innovations in Immunology 1

You have accessRestricted access
Evaluation of Peripheral Blood Leukocyte Subsets in Systemic Lupus Erythematosus (SLE) Enabled by a Microfluidic Cell Separator
Mikhail Olferiev, Dina Greenman, Nitin Kulnarni, Peng Meng Kou, Kyle C Smith and Mary K Crow

J Immunol 204 (1 Supplement) 86.18; May 1, 2020,
You have accessRestricted access
Expediting antibody discovery using Bioelectronica’s HypercellTM platform
Tian Yu, Jonathan Hull, Andrea Ruiz, Ashwini Bhat and Amar Basu

J Immunol 204 (1 Supplement) 86.36; May 1, 2020,
You have accessRestricted access
Use of TCR-mimic bispecific antibodies against pMHC-II for monitoring antigen processing and redirecting cytolytic effector cells
Srona Sengupta, Jacqueline Douglass, Fengting Wu, Milica Moskovljevic, Madison Reed, Jeanna Yu, Yasmine Tabdili, Emily Han-Chung Hsiue, Rebecca Veenhuis, Bert Vogelstein, Janet Siliciano, Robert Siliciano and Scheherazade Sadegh-Nasseri

J Immunol 204 (1 Supplement) 86.25; May 1, 2020,
You have accessRestricted access
Functional anomaly of CD8 T cells at earlier differentiation stages during HIV infection as established by analysis of synaptic interface and degranulation pattern
Nadia Anikeeva, Maria Steblyanko, Leticia Kuri-Cervantes, Marcus Buggert, Michael R Betts and Yuri Sykulev

J Immunol 204 (1 Supplement) 86.46; May 1, 2020,
You have accessRestricted access
A Unique Multiplex Assay to Identify Th1/Th2 Cytokine Profile in MS Patients
Charitha Madiraju, Jacob Alexander Karp, Martha Oppong and Robert Matson

J Immunol 204 (1 Supplement) 86.26; May 1, 2020,
You have accessRestricted access
Assessment of Antibody Functional Affinity using FluoroSpot
Greg A Kirchenbaum, Giuseppe A Sautto, Rodrigo B Abreu, Paul V Lehmann and Ted M Ross

J Immunol 204 (1 Supplement) 86.11; May 1, 2020,
You have accessRestricted access
Expansion of natural killer cells with optimal killing activity for cancer immunotherapy
Kevin Flynn, Christine A. Goetz, Jamie Van Etten, Christopher Hammerbeck, Li Peng, Neil Lee, Joyce Liang, Daniel O-Reilly, Greg Herr, Thuy Tong, Dave Finkel, Mandy Kubik and Jody L Bonnevier

J Immunol 204 (1 Supplement) 86.14; May 1, 2020,
You have accessRestricted access
A new therapeutic influenza virus vaccine that uses host cell-restricted attenuation by artificial microRNAs
Hua Guo, Ke Wen, Haiyan Wang, Yanping Chen, Xing Yang, Huixiao Yang, Adilene Realivazquez Pena and Mingtao Zeng

J Immunol 204 (1 Supplement) 86.16; May 1, 2020,
You have accessRestricted access
Evaluation of oligonucleotide conjugated antibodies as reporter molecules in single-cell assays
Chikara Takahashi, Amelia Au-Yeung, Johnny Gutierrez, Shadi Toghi-Eshghi, Rod Mathews and William O’Gorman

J Immunol 204 (1 Supplement) 86.35; May 1, 2020,
You have accessRestricted access
Targeted CRISPR/Cas9-based in vitro and in vivo screening of metabolic pathways in primary T cells
Ayaka Sugiura, Katherine L. Beier and Jeffrey C. Rathmell

J Immunol 204 (1 Supplement) 86.33; May 1, 2020,

Main menu

User menu

Search

More articles from Technological Innovations in Immunology 1

Pages

Navigate

For Authors

General Information

Journal Services